Can Pharmacists Afford not to Champion Medication Safety?

Abstract

Journal of Pharmacy Practice and ResearchVolume 40, Issue 3 p. 176-177 EditorialFree Access Can Pharmacists Afford not to Champion Medication Safety? Tuck Seng Wu BPharm (Hons), MHSM, MRPharmS, AMIChemE, Tuck Seng Wu BPharm (Hons), MHSM, MRPharmS, AMIChemE Editorial Advisory Board Member Journal of Pharmacy Practice and Research, and Deputy Director of Pharmacy [email protected] National University Hospital, Singapore, 119074Search for more papers by this author Tuck Seng Wu BPharm (Hons), MHSM, MRPharmS, AMIChemE, Tuck Seng Wu BPharm (Hons), MHSM, MRPharmS, AMIChemE Editorial Advisory Board Member Journal of Pharmacy Practice and Research, and Deputy Director of Pharmacy [email protected] National University Hospital, Singapore, 119074Search for more papers by this author First published: 13 April 2015 https://doi.org/10.1002/j.2055-2335.2010.tb00531.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 LT Kohn, JM Corrigan, MS Donaldson, editors. To err is human – building a safer health system. Washington: National Academy Press; 2000. 2Rinehart JR. Conundrums within a culture of safety. Am J Health Syst Pharm 2010; 67: 1206– 7. 3Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274: 35– 43. 4Bates DW. Frequency, consequences and prevention of adverse drug events. J Qual Clin Pract 1999; 19: 13– 17. 5Ernst FR, Grizzle AJ. Drug-related morbidity and mortality – updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192– 9. Citing Literature Volume40, Issue3September 2010Pages 176-177 ReferencesRelatedInformation